| 1 |
Wang X, Yu W, Jiang G, et al. Global epidemiology of gallstones in the 21st century: A systematic review and meta-analysis [J]. Clin Gastroenterol Hepatol, 2024, 22(8): 1586-1595.
|
| 2 |
Patel H, Jepsen J. Gallstone disease: common questions and answers [J]. Am Fam Physician, 2024, 109(6): 518-524.
|
| 3 |
Diehl AK. Gallstone size and the risk of gallbladder cancer [J]. JAMA, 1983, 250(17): 2323-2326.
|
| 4 |
Lowenfels AB, Walker AM, Althaus DP, et al. Gallstone growth, size, and risk of gallbladder cancer: an interracial study [J]. Int J Epidemiol, 1989, 18(1): 50-54.
|
| 5 |
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome [J]. Clin Epidemiol, 2014, 6: 99-109.
|
| 6 |
Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease [J]. Lancet, 2006, 368(9531): 230-239.
|
| 7 |
Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone disease [J]. Best Pract Res Clin Gastroenterol, 2006, 20(6): 981-996.
|
| 8 |
Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones [J]. Gastroenterol Clin North Am, 2010, 39(2): 157-169.
|
| 9 |
Cheng S, Zhang Y, Jiang L, et al. The association between inflammatory biomarkers and gallstones in Americans under 50 years old [J]. BMC Gastroenterol, 2025, 25(1): 393.
|
| 10 |
Zhang M, Mao M, Zhang C, et al. Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis [J]. Lipids Health Dis, 2022, 21(1): 26.
|
| 11 |
Soran H, Schofield JD, Durrington PN. Antioxidant properties of HDL [J]. Front Pharmacol, 2015, 6: 222.
|
| 12 |
Jiang Z, Jiang H, Zhu X, et al. The relationship between high-sensitivity C-reactive protein and gallstones: a cross-sectional analysis [J]. Front Med (Lausanne), 2024, 11: 1453129.
|
| 13 |
Rye KA, Barter PJ. Antiinflammatory actions of HDL: a new insight [J]. Arterioscler Thromb Vasc Biol, 2008, 28(11): 1890-1891.
|
| 14 |
Taborda NA, Blanquiceth Y, Urcuqui-Inchima S, et al. High-density lipoproteins decrease proinflammatory activity and modulate the innate immune response [J]. J Interferon Cytokine Res, 2019, 39(12): 760-770.
|
| 15 |
Niyonzima N, Samstad EO, Aune MH, et al. Reconstituted high-density lipoprotein attenuates cholesterol crystal-induced inflammatory responses by reducing complement Activation [J]. J Immunol, 2015, 195(1): 257-264.
|
| 16 |
Rosenson RS, Brewer HB Jr, Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease [J]. Nat Rev Cardiol, 2016, 13(1): 48-60.
|
| 17 |
Warnatsch A, Ioannou M, Wang Q, et al. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis [J]. Science, 2015, 349(6245): 316-320.
|
| 18 |
Liu Z, Fan Q, Wu S, et al. Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson's disease [J]. Lipids Health Dis, 2021, 20(1): 35.
|
| 19 |
Lai H, Tu Y, Zhang S, et al. Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study [J]. Ann Hematol, 2023, 102(12): 3413-3426.
|
| 20 |
Chen T, Chen H, Xiao H, et al. Comparison of the value of neutrophil to high-density lipoprotein cholesterol ratio and lymphocyte to high-density lipoprotein cholesterol ratio for predicting metabolic syndrome among a population in the southern coast of China [J]. Diabetes Metab Syndr Obes, 2020, 13: 597-605.
|
| 21 |
Liu M, Liu X, Wei Z, et al. MHR and NHR but not LHR were associated with coronary artery disease in patients with chest pain with controlled LDL-C [J]. J Investig Med, 2022, 70(7): 1501-1507.
|
| 22 |
Liu X, Yan G, Xu B, et al. Association between monocyte-to-high-density lipoprotein-cholesterol ratio and gallstones in U.S. adults: findings from the National Health and Nutrition Examination Survey 2017-2020 [J]. Lipids Health Dis, 2024, 23(1): 173.
|
| 23 |
Ma D, Ma H, Li Y, et al. Association between Neutrophil-to-high-density lipoprotein-cholesterol ratio and gallstones: insights from the national health and nutrition examination survey (2017-2020) [J]. Lipids Health Dis, 2024, 23(1): 355.
|
| 24 |
Fu C, Chen J, Liu K, et al. Evaluating the link between high-density lipoprotein-related inflammatory indices and gallstone disease in U.S. adults [J]. Mediators Inflamm, 2026, 2026: 1925004.
|
| 25 |
Li H, Zhang C. Association between triglyceride-glucose index and gallstones: a cross-sectional study [J]. Sci Rep, 2024, 14(1): 17778.
|
| 26 |
Meng C, Liu K. Higher levels of systemic immune-inflammatory index are associated with the prevalence of gallstones in people under 50 years of age in the United States: a cross-sectional analysis based on NHANES [J]. Front Med (Lausanne), 2023, 10: 1320735.
|
| 27 |
Cho SK, Jung S, Lee KJ, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio can predict the severity of gallstone pancreatitis [J]. BMC Gastroenterol, 2018, 18(1): 18.
|
| 28 |
Wang Y, Shang X, Zhang Y, et al. The association between neutrophil to high-density lipoprotein cholesterol ratio and gallstones: a cross-sectional study [J]. BMC Public Health, 2025, 25(1): 157.
|
| 29 |
Su Z, Gong Y, Liang Z. Prevalence of gallstone in Mainland China: A meta-analysis of cross-sectional studies [J]. Clin Res Hepatol Gastroenterol, 2020, 44(4): e69-e71.
|
| 30 |
Wang HH, Afdhal NH, Wang DQ. Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones [J]. Gastroenterology, 2004, 127(1): 239-249.
|
| 31 |
Cirillo DJ, Wallace RB, Rodabough RJ, et al. Effect of estrogen therapy on gallbladder disease [J]. JAMA, 2005, 293(3): 330-339.
|
| 32 |
Shengelia M, Intskirveli N, Gogebashvili N. Inflammatory markers of gallstones disease in menopausal women [J]. Georgian Med News, 2012, (208-209): 52-55.
|
| 33 |
Maurer KJ, Rao VP, Ge Z, et al. T-cell function is critical for murine cholesterol gallstone formation [J]. Gastroenterology, 2007, 133(4): 1304-1315.
|
| 34 |
Muñoz LE, Boeltz S, Bilyy R, et al. Neutrophil extracellular traps initiate gallstone formation [J]. Immunity, 2019, 51(3): 443-450.e4.
|
| 35 |
Ouyang FW, Chiang HH, Hsu WL, et al. Dysfunctional high-density lipoprotein: an updated review [J]. Front Cardiovasc Med, 2025, 12: 1713387.
|
| 36 |
Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy [J]. N Engl J Med, 2011, 365(24): 2255-2267.
|
| 37 |
Rohatgi A, Khera A, Berry JD, et al. HDL cholesterol efflux capacity and incident cardiovascular events [J]. N Engl J Med, 2014, 371(25): 2383-2393.
|